-
1.发明授权公开(公告)号：US09314483B2
公开(公告)日：2016-04-19
申请号：US14303212
申请日：2014-06-12
Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Inventor： Michal Eisenbach-Schwartz , Ester Yoles , Ravid Shechter , Omer Miller
IPC: C12N5/0786 , A61K35/15 , A61K35/14 , A61K35/12
CPC classification number: A61K35/15 , A61K35/14 , A61K2035/124 , C12N5/0645
Abstract: A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.
Abstract translation: 提供了用于治疗CNS损伤的基本上不含CD3 +细胞，CD19 +细胞，CD56 +细胞和任选的CD16 +细胞的外周血单核细胞（PBMC）的亚群。
-
2.发明申请HUMAN MONOCYTE SUB-POPULATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM INJURY 有权用于治疗中枢神经系统损伤的人类单克隆人群公开(公告)号：US20140363411A1
公开(公告)日：2014-12-11
申请号：US14303212
申请日：2014-06-12
Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Inventor： Michal Eisenbach-Schwartz , Ester Yoles , Ravid Schechter , Omer Miller
IPC: A61K35/14
CPC classification number: A61K35/15 , A61K35/14 , A61K2035/124 , C12N5/0645
Abstract: A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.
Abstract translation: 提供了用于治疗CNS损伤的基本上没有CD3 +细胞，CD19 +细胞，CD56 +细胞和任选的CD16 +细胞的外周血单核细胞（PBMC）的亚群。
-
Search Results
2
records
(took 0.012 seconds)
